“TARGETING MULTI-MICROBIAL INFECTION IN CHRONIC WOUNDS THROUGH TRIPLE ANTIBIOTIC NANOEMULGEL FORMULATION”

NIPA THACKER; RICHA DAYARAMANI; SUNNY RATHEE

doi:10.22159/ijpps.2025v17i10.55958

Authors

NIPA THACKER Gujarat Technological University, Chandkheda, Ahmedabad, Gujarat-382424, India https://orcid.org/0009-0002-4132-7002
RICHA DAYARAMANI Centre of Excellence in Medical Devices, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Opposite Air Force Station, Palaj, Gandhinagar-382355, Gujarat, India https://orcid.org/0000-0002-8615-6529
SUNNY RATHEE Centre of Excellence in Medical Devices, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Opposite Air Force Station, Palaj, Gandhinagar-382355, Gujarat, India https://orcid.org/0000-0003-2896-5982

DOI:

https://doi.org/10.22159/ijpps.2025v17i10.55958

Keywords:

Nanoemulgel, Triple-antibiotic, Metronidazole, Norfloxacin, Mupirocin, Higuchi kinetics, Diabetic wound

Abstract

Objective: Chronic diabetic wounds are challenging to treat due to multi-microbial infections. This study developed an innovative triple-antibiotic nanoemulgel formulation (TANF) that integrates metronidazole, norfloxacin, and mupirocin, targeting anaerobic bacteria, Gram-negative bacteria, and Gram-positive bacteria, respectively. The objective was to create a wide-spectrum, effective topical therapy with superior drug delivery characteristics.

Methods: Six nanoemulgel batches were prepared using high-speed homogenization, with 0.5% Hydroxypropyl Methylcellulose (HPMC) E15 as the gelling agent in batch F1. The formulation incorporated tea tree oil and coconut oil as penetration enhancers. Comprehensive physicochemical characterization included drug content, pH, spreadability, skin permeability, and in vitro drug release studies. Drug release kinetics was analyzed, and stability investigations were initiated.

Results: Batch F1 demonstrated optimal performance, achieving drug release of 90.12% Metronidazole, 89.56% Norfloxacin, and 90.79% Mupirocin within 24 h. The formulation maintained pH levels between 6-6.5, over 95% drug content, and excellent spreadability. Higuchi kinetics governed the drug release, and the inclusion of penetration enhancers significantly improved skin permeability. The nanoemulgel exhibited reduced greasiness and a dual control release mechanism, addressing limitations in traditional topical formulations.

Conclusion: The developed TANF demonstrated strong, broad-spectrum antimicrobial activity and enhanced drug delivery, making it a promising topical therapy for chronic diabetic wounds. Its optimized formulation ensures effective microbial coverage and improved patient compliance. Ongoing stability studies will confirm its long-term safety and efficacy.

Downloads

Download data is not yet available.

References

1. Anand K, Ray S, Rahman M, Shaharyar A, Bhowmik R, Bera R. Nano-emulgel: emerging as a smarter topical lipidic emulsion-based nanocarrier for skin healthcare applications. Recent Pat Anti-Infect Drug Discov. 2019;14(1):16-35. doi: 10.2174/1574891X14666190717111531, PMID 31333141.

2. Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. Pharmaceutics. 2023 Jan 3;15(1):164. doi: 10.3390/pharmaceutics15010164, PMID 36678794, PMCID PMC9863395.

3. Yu M, Ma H, Lei M, Li N, Tan F. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties. Eur J Pharm Biopharm. 2014;88(1):92-103. doi: 10.1016/j.ejpb.2014.03.019, PMID 24704200.

4. Najm MB, Rawas Qalaji M, Assar NH, Yahia R, El Hosary RE, Ahmed IS. Optimization characterization and in vivo evaluation of mupirocin nanocrystals for topical administration. Eur J Pharm Sci. 2022;176:106251. doi: 10.1016/j.ejps.2022.106251, PMID 35788029.

5. Dua K, Malipeddi VR, Madan J, Gupta G, Chakravarthi S, Awasthi R. Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds. Interv Med Appl Sci. 2016 Jun 30;8(2):68-76. doi: 10.1556/1646.8.2016.2.4, PMID 28386462.

6. Dave V, Yadav RB, Kushwaha K, Yadav S, Sharma S, Agrawal U. Lipid polymer hybrid nanoparticles: development and statistical optimization of norfloxacin for topical drug delivery system. Bioact Mater. 2017 Dec 1;2(4):269-80. doi: 10.1016/j.bioactmat.2017.07.002, PMID 29744436.

7. Choudhury H, Gorain B, Pandey M, Chatterjee LA, Sengupta P, Das A. Recent update on nanoemulgel as topical drug delivery system. J Pharm Sci. 2017 Jul;106(7):1736-51. doi: 10.1016/j.xphs.2017.03.042, PMID 28412398.

8. Aithal GC, Narayan R, Nayak UY. Nanoemulgel: a promising phase in drug delivery. Curr Pharm Des. 2020;26(2):279-91. doi: 10.2174/1381612826666191226100241, PMID 31878849.

9. Ullah N, Amin A, Farid A, Selim S, Rashid SA, Aziz MI. Development and evaluation of essential oil-based nanoemulgel formulation for the treatment of oral bacterial infections. Gels. 2023 Mar 21;9(3):252. doi: 10.3390/gels9030252, PMID 36975701, PMCID PMC10048686.

10. Singh I, Kaur P, Kaushal U, Kaur V, Shekhar N. Essential oils in treatment and management of dental diseases. Biointerf Res Appl Chem. 2022;12(6):7267-86. doi: 10.33263/briac126.72677286.

11. Ma Q, Zhang J, Lu B, Lin H, Sarkar R, Wu T. Nanoemulgel for improved topical delivery of desonide: formulation design and characterization. AAPS Pharm Sci Tech. 2021;22(5):163. doi: 10.1208/s12249-021-02035-5, PMID 34031790.

12. Azhar M, Amul Mishra. Review of nanoemulgel for treatment of fungal infections. Int J Pharm Pharm Sci. 2024 May 21;16(9):8-17. doi: 10.22159/ijpps.2024v16i9.51528.

13. Hmingthansanga V, Singh N, Banerjee S, Manickam S, Velayutham R, Natesan S. Improved topical drug delivery: role of perme

14. ation enhancers and advanced approaches. Pharmaceutics. 2022 Dec 15;14(12):2818. doi: 10.3390/pharmaceutics14122818, PMID 36559311.

15. Lane ME. Skin penetration enhancers. Int J Pharm. 2013 Apr 15;447(1-2):12-21. doi: 10.1016/j.ijpharm.2013.02.040, PMID 23462366.

16. Chellapa P, Eid A, Elmarzugi N. Preparation and characterization of virgin coconut oil nanoemulgel. 2015;7(9):787-93.

17. Bujubarah MM, Elsewedy HS, Shehata TM, Soliman WE. Formulation by design of an innovative tea tree oil nanoemulgel incorporating mupirocin for enhanced wound healing activity. Appl Sci. 2023;13(24):13244. doi: 10.3390/app132413244.

18. Silva RC, Trevisan MG, Garcia JS. Characterization and drug excipient compatibility study of bromopride by DSC, FTIR and HPLC. J Therm Anal Calorim. 2024;149(17):9333-42. doi: 10.1007/s10973-024-13392-1.

19. Bruni G, Amici L, Berbenni V, Marini A, Orlandi A. Drug excipient compatibility studies search of interaction indicators. J Therm Anal Calorim. 2002 May 1;68(2):561-73. doi: 10.1023/A:1016052121973.

20. Ahmad J, Gautam A, Komath S, Bano M, Garg A, Jain K. Topical nano-emulgel for skin disorders: formulation approach and characterization. Recent Pat Antiinfect Drug Discov. 2019 May 1;14(1):36-48. doi: 10.2174/1574891X14666181129115213, PMID 30488798.

21. Gadkari PN, Patil PB, Saudagar RB. Formulation development and evaluation of topical nanoemulgel of tolnaftate. J Drug Deliv Ther. 2019 Mar 2;9(2):208-13. doi: 10.22270/jddt.v9i2-s.2495.

22. Algahtani MS, Ahmad MZ, Shaikh IA, Abdel Wahab BA, Nourein IH, Ahmad J. Thymoquinone loaded topical nanoemulgel for wound healing: formulation design and in vivo evaluation. Molecules. 2021 Jun 24;26(13):3863. doi: 10.3390/molecules26133863, PMID 34202733.

23. Bashir M, Ahmad J, Asif M, Khan SU, Irfan M, Y Ibrahim A. Nanoemulgel an innovative carrier for diflunisal topical delivery with profound anti-inflammatory effect: in vitro and in vivo evaluation. Int J Nanomedicine. 2021;16:1457-72. doi: 10.2147/IJN.S294653, PMID 33654396.

24. Priyadarshini P, Karwa P, Syed A, Asha AN. Formulation and evaluation of nanoemulgels for the topical drug delivery of posaconazole. J Drug Deliv Ther. 2023;13(1):33-43. doi: 10.22270/jddt.v13i1.5896.

25. Tashtoush BM, Jacobson EL, Jacobson MK. Validation of a simple and rapid HPLC method for determination of metronidazole in dermatological formulations. Drug Dev Ind Pharm. 2008 Jan 1;34(8):840-4. doi: 10.1080/03639040801928598, PMID 18618307.

26. Echevarria L, Blanco Prieto MJ, Campanero MA, Santoyo S, Ygartua P. Development and validation of a liquid chromatographic method for in vitro mupirocin quantification in both skin layers and percutaneous penetration studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Nov 5;796(2):233-41. doi: 10.1016/j.jchromb.2003.07.011, PMID 14581064.

27. Chierentin L, Salgado HR. Review of properties and analytical methods for the determination of norfloxacin. Crit Rev Anal Chem. 2016 Jan 2;46(1):22-39. doi: 10.1080/10408347.2014.941456, PMID 26398574.

28. Donthi MR, Saha RN, Singhvi G, Dubey SK. Dasatinib-loaded topical nano-emulgel for rheumatoid arthritis: formulation design and optimization by QbD, in vitro, ex vivo, and in vivo evaluation. Pharmaceutics. 2023;15(3):736. doi: 10.3390/pharmaceutics15030736, PMID 36986597.

29. Barkat MA, Hasan N, Hassan MohdZ, Asiri YI, Nadaf A, Ahmad FJ. Formulation development of methotrexate lipid-based nanogel for treatment of skin cancer. Colloids Surf A Physicochem Eng Aspects. 2024 May 5;688:133571, doi: 10.1016/j.colsurfa.2024.133571.

30. Gaber DA, Alsubaiyel AM, Alabdulrahim AK, Alharbi HZ, Aldubaikhy RM, Alharbi RS. Nano-emulsion-based gel for topical delivery of an anti-inflammatory drug: in vitro and in vivo evaluation. Drug Des Dev Ther. 2023;17:1435-51. doi: 10.2147/DDDT.S407475, PMID 37216175.

31. Sghier K, Mur M, Veiga F, Paiva Santos AC, Pires PC. Novel therapeutic hybrid systems using hydrogels and nanotechnology: a focus on nanoemulgels for the treatment of skin diseases. Gels. 2024 Jan 6;10(1):45. doi: 10.3390/gels10010045, PMID 38247768, PMCID PMC10815052.

32. Manure Hirakant S, Nagoba Shivappa N. Design development and evaluation of novel nanoemulgel for topical drug delivery system. J Biomech Sci Eng. 2023 Jul:84-99.

33. Pereira GF, Balmith M, Nell M. The efficacy of honey as an alternative to standard antiseptic care in the treatment of chronic pressure ulcers and diabetic foot ulcers in adults. Asian J Pharm Clin Res. 2021;5(6):37-47. doi: 10.22159/ajpcr.2021.v14i11.42560.

34. Thakre S Chanchlesh Dehariya, Shivam Upadhyay, Shailendra Singh Nargesh, Manisha Singh. A prospective study of epidemiological factors and outcome in patients of diabetic foot wound attending J. A Group of Hospitals: A Tertiary Care Centre. 2023 Jun;16(6):149-52. doi: 10.22159/ajpcr.2023.v16i6.48316.

35. Manasa MT, Ramanamurthy KV, Bhupathi PA. Electrospun nanofibrous wound dressings: a review on chitosan composite nanofibers as potential wound dressings. Int J App Pharm. 2023 Jul;15(4):1. doi: 10.22159/ijap.2023v15i4.47912.

36. Alhasso B, Ghori MU, Conway BR. Development of nanoemulsions for topical application of mupirocin. Pharmaceutics. 2023;15(2):378. doi: 10.3390/pharmaceutics15020378, PMID 36839700.

37. Ullah N, Amin A, Farid A, Selim S, Rashid SA, Aziz MI. Development and evaluation of essential oil based nanoemulgel formulation for the treatment of oral bacterial infections. Gels. 2023 Mar 21;9(3):252. doi: 10.3390/gels9030252, PMID 36975701.

38. Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. Pharmaceutics. 2023 Jan 3;15(1):164. doi: 10.3390/pharmaceutics15010164, PMID 36678794.

39. Yetukuri K, Umashankar MS. Development and optimization of Kunzea ericoides nanoemulgel using a quality by design approach for transdermal anti-inflammatory therapy. Gels. 2025 May 27;11(6):400. doi: 10.3390/gels11060400, PMID 40558699.

40. Manure Hirakant S, Nagoba Shivappa N. Design development and evaluation of novel nanoemulgel for topical drug delivery system. J Biomech Sci Eng. 2023:84-99.

41. Gaddala P, Choudhary S, Sethi S, Sainaga Jyothi VG, Katta C, Bahuguna D. Etodolac utility in osteoarthritis: drug delivery challenges topical nanotherapeutic strategies and potential synergies. Ther Deliv. 2024 Dec 1;15(12):977-95. doi: 10.1080/20415990.2024.2405456, PMID 39345034.

42. Rehman SU, Khan NR, Ullah M, Shah SU, Rehman AU, Jamal Q. Nanoemulgel mediated enhanced skin curcumin penetration/retention for local treatment of cutaneous leishmaniasis: in vitro and in vivo assessment. Drug Dev Ind Pharm. 2025 Apr 3;51(4):354-64. doi: 10.1080/03639045.2025.2473495, PMID 40022627.